• English

    Google Translate Disclaimer

    The Maryland Department of Information Technology (“DoIT”) offers translations of the content through Google Translate. Because Google Translate is an external website, DoIT does not control the quality or accuracy of translated content. All DoIT content is filtered through Google Translate which may result in unexpected and unpredictable degradation of portions of text, images and the general appearance on translated pages. Google Translate may maintain unique privacy and use policies. These policies are not controlled by DoIT and are not associated with DoIT’s privacy and use policies. After selecting a translation option, users will be notified that they are leaving DoIT’s website. Users should consult the original English content on DoIT’s website if there are any questions about the translated content.

    DoIT uses Google Translate to provide language translations of its content. Google Translate is a free, automated service that relies on data and technology to provide its translations. The Google Translate feature is provided for informational purposes only. Translations cannot be guaranteed as exact or without the inclusion of incorrect or inappropriate language. Google Translate is a third-party service and site users will be leaving DoIT to utilize translated content. As such, DoIT does not guarantee and does not accept responsibility for, the accuracy, reliability, or performance of this service nor the limitations provided by this service, such as the inability to translate specific files like PDFs and graphics (e.g. .jpgs, .gifs, etc.).

    DoIT provides Google Translate as an online tool for its users, but DoIT does not directly endorse the website or imply that it is the only solution available to users. All site visitors may choose to use alternate tools for their translation needs. Any individuals or parties that use DoIT content in translated form, whether by Google Translate or by any other translation services, do so at their own risk. DoIT is not liable for any loss or damages arising out of, or issues related to, the use of or reliance on translated content. DoIT assumes no liability for any site visitor’s activities in connection with use of the Google Translate functionality or content.

    The Google Translate service is a means by which DoIT offers translations of content and is meant solely for the convenience of non-English speaking users of the website. The translated content is provided directly and dynamically by Google; DoIT has no direct control over the translated content as it appears using this tool. Therefore, in all contexts, the English content, as directly provided by DoIT is to be held authoritative.


    Maryland Register

    Issue Date:  December 21, 2018

    Volume 45 • Issue 26 • Page 1267-1268

    Title 10 

    Subtitle 34 BOARD OF PHARMACY

    10.34.09 Fees

    Authority: Health Occupations Article, §12-205, Annotated Code of Maryland

    Notice of Proposed Action


         The Secretary of Health proposes to amend Regulation .02 under COMAR 10.34.09 Fees. This action was considered by the Board of Pharmacy at an open meeting held on July 18, 2018, notice of which was given by publication on the Board of Pharmacy website, http://health.maryland.gov/pharmacy/Pages/index.aspx, from July 13—18, 2018.

    Statement of Purpose

    The purpose of this action is to eliminate an administrative fee when the Board of Pharmacy reviews a pharmacy technician training program that includes a didactic portion that is identical to a program which the Board of Pharmacy has previously approved. The fee is not necessary because no additional administrative resources are expended by the Board of Pharmacy.

    Comparison to Federal Standards

    There is no corresponding federal standard to this proposed action.

    Estimate of Economic Impact

    I. Summary of Economic Impact. Based on data from Fiscal Year 2018, the potential loss of fees to the Board, and the corresponding benefit to licensees, as a result of this change is not likely to exceed $300.



    Revenue (R+/R-)


    II. Types of Economic Impact.






    A. On issuing agency:



    B. On other State agencies:


    C. On local governments:




    Benefit (+)
    Cost (-)




    D. On regulated industries or trade groups:



    E. On other industries or trade groups:


    F. Direct and indirect effects on public:



    III. Assumptions. (Identified by Impact Letter and Number from Section II.)

    A. and D. The economic impact would be approximately $300 loss in fees to the Board and a benefit to the licensees in the same amount. This assumption is based on the fact that only two programs in the past year might have been affected by this change. (2 x $100 = $200). The calculation of a potential $300 impact allows for a variance of one additional fee.

    Economic Impact on Small Businesses

    The proposed action has minimal or no economic impact on small businesses.

    Impact on Individuals with Disabilities

    The proposed action has no impact on individuals with disabilities.

    Opportunity for Public Comment

    Comments may be sent to Jake Whitaker, Acting Director, Office of Regulation and Policy Coordination, Maryland Department of Health, 201 West Preston Street, Room 512, Baltimore, MD 21201, or call 410-767-6499 (TTY 800-735-2258), or email to mdh.regs@maryland.gov, or fax to 410-767-6483. Comments will be accepted through January 22, 2019. A public hearing has not been scheduled.

    .02 Fees.

    The following fees are established by the Board:

    A.—C. (text unchanged)

    D. Pharmacy Technician Fees.

    (1)—(2) (text unchanged)

    (3) Pharmacy technician reinstatement fee — $45; [and]

    (4) Review of pharmacy technician training programs submitted to the Board for approval — $100; and

    (5) Review of pharmacy technician training programs submitted to the Board for approval that include a didactic portion that is comprised entirely of a didactic program that has already been approved by the Board  —  no charge.

    D-1.—E. (text unchanged)

    Secretary of Health